Blue World Acquisition Corp. operates as a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The company was founded on July 19, 2021 and is headquartered in New York, NY.

Singularity Future Technology Ltd. is a global logistics and ship management services company. It provides tailored solutions and value-added services to its customers to drive efficiency and control in related steps throughout the entire shipping and freight logistics chain. It operates through the following segments: Shipping Agency and Management Services, Freight Logistics Services, and Container Trucking Services. The company was founded by Lei Cao on April 2001 and is headquartered in Great Neck, NY.

Bionomics Ltd. is a clinical stage biopharmaceutical company. It engages in the development of novel drug candidates focused on the treatment of serious central nervous system disorders. Its lead product candidate is BNC210. The company was founded in 1996 and is headquartered in Eastwood, Australia.

Serve Robotics Inc. designs, develops, and operates low-emission robots that serve people in public spaces with food delivery in the United States. It builds self-driving delivery robots. The company was formerly known as Patricia Acquisition Corp. and changed its name to Serve Robotics Inc. in July 2023. Serve Robotics Inc. was founded in 2017 and is based in Redwood City, California.

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Airship AI Holdings, Inc. engages in a video, sensor, and data management surveillance platform, that focuses on the provision of software services. Its products include Airship Acropolis OS, Airship Command, and Airship Outpost. The company was founded in 2003, and is headquartered in Redmond, WA.

AERWINS Technologies, Inc. engages in the development of technologies to enable air mobility. It has developed XTURISMO, a hoverbike, and the C.O.S.M.O.S. flight operation management system. It also offers drone-based solution services. The company was founded in 2017 and is headquartered in Middletown, DE.

SolarMax Technology, Inc. is an integrated solar and renewable energy company. The firm engages in the provision of global energy solutions for residential and commercial markets. Its solar products include home solar, SMX solar panels, home battery, and electric car charging. The firm operates through the following segments: the United States and China. The United States operations consist of the sale and installation of photovoltaic and battery backup systems for residential and commercial customers, and sales of LED systems and services to government and commercial users. The China operations consist of identifying and procuring solar farm projects for resale to third parties and performing EPC services for solar farm projects. The company was founded by David Hsu, Simon Yuan and Ching Liu in January 2008 and is headquartered in Riverside, CA.

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.